Does CABAZITAXEL Cause Prostate cancer? 63 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Prostate cancer have been filed in association with CABAZITAXEL (Jevtana). This represents 2.5% of all adverse event reports for CABAZITAXEL.
63
Reports of Prostate cancer with CABAZITAXEL
2.5%
of all CABAZITAXEL reports
14
Deaths
9
Hospitalizations
How Dangerous Is Prostate cancer From CABAZITAXEL?
Of the 63 reports, 14 (22.2%) resulted in death, 9 (14.3%) required hospitalization, and 1 (1.6%) were considered life-threatening.
Is Prostate cancer Listed in the Official Label?
Yes, Prostate cancer is listed as a known adverse reaction in the official FDA drug label for CABAZITAXEL.
What Other Side Effects Does CABAZITAXEL Cause?
Febrile neutropenia (197)
Malignant neoplasm progression (172)
Fatigue (160)
Prostatic specific antigen increased (148)
Pyrexia (145)
Disease progression (143)
Diarrhoea (142)
Anaemia (127)
Neutropenia (126)
Drug ineffective (125)
What Other Drugs Cause Prostate cancer?
RANITIDINE (60,641)
LEUPROLIDE (1,736)
ABIRATERONE (661)
ENZALUTAMIDE (642)
ADALIMUMAB (573)
ETANERCEPT (482)
METHOTREXATE (444)
INFLIXIMAB (376)
LENALIDOMIDE (366)
PREDNISONE (317)
Which CABAZITAXEL Alternatives Have Lower Prostate cancer Risk?
CABAZITAXEL vs CABERGOLINE
CABAZITAXEL vs CABOTEGRAVIR
CABAZITAXEL vs CABOTEGRAVIR\RILPIVIRINE
CABAZITAXEL vs CABOZANTINIB
CABAZITAXEL vs CABOZANTINIB S-MALATE